Meanwhile, it showed certain anti-tumor activity in the treatment of GIST with KIT D816H, V560G, V654A, and PDGFRA D842V mutation.7,8 Anlotinib and sunitinib may have different sensitivity to different gene mutation types in the inhibition of GIST. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.